Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma(MM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT05052970
What this trial is testing

Mitoxantrone Hydrochloride Liposome Injection, Bortezomib and Dexamethasone in the Treatment of R/R MM

Who this might be right for
Relapsed or Refractory Multiple Myeloma
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 60
Testing effectiveness (Phase 2)Ended earlyNCT00396383
What this trial is testing

Treatment With AMD3100 (Plerixafor) in MM Patients to Mobilize PBCs For Collection and for Transplantation

Who this might be right for
Multiple Myeloma
Genzyme, a Sanofi Company 9
Post-approval studies (Phase 4)Looking for participantsNCT07025005
What this trial is testing

Fenofibrate Role in the Prophylaxis From Peripheral Neuropathy Induced by Bortezomib, Lenalidomide and Dexamethasone (VRd) Protocol in the Treatment of Patients With Multiple Myeloma (MM)

Who this might be right for
Peripheral NeuropathyMultiple Myeloma, Neoplasms
Tanta University 44
Early research (Phase 1)Active Not RecruitingNCT05775094
What this trial is testing

Romosozumab in Women With Multiple Myeloma and Osteoporosis

Who this might be right for
OsteoporosisMultiple Myeloma
Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)Ended earlyNCT03733691
What this trial is testing

Ph 2 Maintenance Trial: Ixazomib vs Ixazomib-Lenalidomide for MM Patients

Who this might be right for
Newly Diagnosed Multiple Myeloma
Oncotherapeutics 19
Early research (Phase 1)Study completedNCT01575925
What this trial is testing

Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)

Who this might be right for
Multiple MyelomaRenal Impairment
Celgene 25
Not applicableActive Not RecruitingNCT05844033
What this trial is testing

Biomarker for Infection Risk in CLL and MM

Who this might be right for
Multiple MyelomaChronic Lymphocytic Leukemia
Massachusetts General Hospital 150
Not applicableActive Not RecruitingNCT04985643
What this trial is testing

Real Life Treatment for Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Takeda 357
Not applicableStudy completedNCT01758042
What this trial is testing

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders

Who this might be right for
Chronic Kidney DiseaseAcute Myeloid Leukemia (AML)Acute Lymphoblastic Leukemia (ALL)+14 more
Massachusetts General Hospital 10
Not applicableLooking for participantsNCT07309497
What this trial is testing

Pragmatic Geriatric Assessment Before CAR-T or Bispecific Antibody Therapy to Predict Side Effects and Outcomes in Older Patients (GA-ACT Trial)

Who this might be right for
Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaCART TherapyBispecific Antibody+1 more
University of Zurich 208
Testing effectiveness (Phase 2)Study completedNCT01302886
What this trial is testing

Study of BHQ880 in Patients With High Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
Novartis Pharmaceuticals 41
Not applicableLooking for participantsNCT05618041
What this trial is testing

The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaLymphomaMultiple Myeloma
Hebei Senlang Biotechnology Inc., Ltd. 50
Testing effectiveness (Phase 2)Study completedNCT07102706
What this trial is testing

Phase I Trial of GR1803 Injection in Patients With RRMM

Who this might be right for
Multiple Myeloma (MM)
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 76
Testing effectiveness (Phase 2)Study completedNCT02203643
What this trial is testing

Evaluation of the Safety and the Efficacy of Carfilzomib Combined With Cyclophosphamide and Dexamethasone (CCyd) or Lenalidomide and Dex (CRd) Followed by ASCT or 12 Cycles of Carf Combined With Dex and Len for Patients Eligible for ASCT With Newly Diagnosed Multiple Myeloma.

Who this might be right for
MULTIPLE MYELOMA (MM)
Mario Boccadoro 477
Testing effectiveness (Phase 2)UnknownNCT00742404
What this trial is testing

Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Oncotherapeutics 35
Not applicableEnded earlyNCT05276622
What this trial is testing

Patient and Care Partner Experiences Living With Multiple Myeloma (PaCE-MM)

Who this might be right for
Multiple Myeloma
UNC Lineberger Comprehensive Cancer Center 64
Testing effectiveness (Phase 2)Study completedNCT00577512
What this trial is testing

2006-32 Phase II Study of Rapidly Recycled High Dose DTPACE

Who this might be right for
Multiple Myeloma
University of Arkansas 4
Post-approval studies (Phase 4)Active Not RecruitingNCT07154537
What this trial is testing

Pneumococcal Conjugated Vaccine 13 (PCV13) for Patients With Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
National Taiwan University Hospital 101
Testing effectiveness (Phase 2)Ended earlyNCT02661022
What this trial is testing

SL-401 in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Stemline Therapeutics, Inc. 9
Testing effectiveness (Phase 2)Study completedNCT00925782
What this trial is testing

PK Study of Melphalan HCL & Alkeran for Injection of MA Conditioning in MM Patients of Autologous Transplantation

Who this might be right for
Multiple Myeloma
Acrotech Biopharma Inc. 24
Next Page